Stocks see best gains in two weeks Print E-mail
By Staff and Wire Reports   
Tuesday, 23 August 2011 17:56
Buyers appeared to return to the stock market Tuesday after deciding the pounding stocks have taken the past month made them too cheap to resist.
The Dow, which tracks 30 huge U.S. companies including IBM Corp. and General Electric Co., closed with a gain of 3 percent at 11,176.76. Indexes that track smaller stocks did even better, a sign that investors were more willing to take on risk. The S&P 500 index rose 38.53 points, or 3.4 percent, to 1,162.35. The Nasdaq composite, which tracks mainly technology companies, rose 100.68 points, or 4.3 percent, to 2,446.06. The Russell 2000 index of smaller U.S. companies gained even more, 4.9 percent.

In healthcare, the speculators appeared to join insiders after nearly every one of the stocks featured in our article about Big Board Healthcare Stocks Being Snapped Up by Insider Executives saw nice gains during Tuesday's action. The only exception was Agenus Inc. (NASDAQ: AGEN), which saw shares climb up then down after a Seeking Alpha writer bashed CEO Armen Garo's sizable purchase of the stock in the open market as a desperate move to avoid de-listing of the company's stock from NASDAQ.

On the flip side, shares of Idenix Pharmaceuticals (Nasdaq: IDIX) continued the steady climb they began seven sessions ago. Shares of the company rose 13.12% to $5.39 +0.62 despite the fact that they traded only half as many shares as usual (54.32 % -vs- Average). IDIX is a biopharmaceutical company engaged in the discovery and development of nucleosides, nucleoside analogs, nucleotides and non-nucleosides to treat viral infectious diseases caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus.

 

Here is a glance at the rest of Tuesday's movers in healthcare:

Gainers (% price change) Last Trade Change Mkt Cap
Hansen Medical, Inc. HNSN 3.08 +0.36 (13.24%) 169.04M
Idenix Pharmaceuticals IDIX 5.39 +0.62 (13.12%) 517.41M
Summer Infant, Inc. SUMR 7.00 +0.79 (12.72%) 122.72M
Immunomedics, Inc. IMMU 3.55 +0.40 (12.70%) 267.74M
Chindex Intl., Inc. CHDX 10.83 +1.17 (12.11%) 182.00M
Losers (% price change)
Gentium S.p.A. (ADR) GENT 6.76 -0.26 (-3.70%) 101.10M
Adolor Corporation ADLR 2.20 -0.07 (-3.08%) 102.22M
Compugen Ltd. (USA) CGEN 3.58 -0.08 (-2.19%) 119.33M
Chelsea Therapeutics Intl CHTP 3.72 -0.04 (-1.06%) 230.07M
3SBio Inc. (ADR) SSRX 13.03 -0.11 (-0.84%) 285.54M
Most Actives (dollar volume)
Johnson & Johnson JNJ 64.97 +1.68 (2.65%) 178.04B
Pfizer Inc. PFE 18.24 +0.56 (3.17%) 142.31B
Merck & Co., Inc. MRK 31.94 +0.63 (2.01%) 98.40B
Medtronic, Inc. MDT 33.10 +1.92 (6.16%) 35.12B
Eli Lilly & Co. LLY 35.92 +0.50 (1.41%) 41.58B

 




"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus
 

Newsletter